
Arsenal acquires BresMed
Arsenal Capital Partners has acquired health economics research provider BresMed Health Solutions.
The acquisition of BresMed is the first in a series of investments Arsenal plans to make to form a new platform in the market access, health economics and outcomes research, patient preference, and evidence sectors.
Arsenal's investment in BresMed is made in partnership with a team of senior executives led by Jon Williams, former CEO of Evidera.
The firm is currently investing from Arsenal Capital Partners V, which closed on $2.36bn in April 2019. The fund was 27% deployed as of December 2019. Arsenal invests $50-300m of equity in healthcare and healthcare-related companies with EBITDA of at least $10m.
Company
Established in 2006, BresMed provides health economics research, communications, and consulting services to the global pharmaceutical industry. Headquartered in Sheffield, the company had office in Manchester, India, the Netherlands, Ireland and the US and around 150 staff as of 31 March 2019.
The company generated an operating loss of £42,507 from revenue of £11.7m for the year ending on 31 March 2019, down from an operating profit of £223,718 from revenue of £11.2 for the preceding year.
People
Arsenal Capital Partners - Gene Gorbach (investment partner).
BresMed Health Solutions – Nic Brereton (CEO, founder).
Advisers
Equity – Ropes & Gray (legal).
Company – Achelous Partners (corporate finance).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds